Archive for November 18th, 2009

Merger Rumors & Chatter Drives Options (BG, MON, NWS, MWW, NUE, SCHN, CL, AMTD, ETFC)

Originally submitted at 2:00 PM EST…. Despite the markets trading a bit lower today there was a lot of call activity today based on takeover chatter in various sectors, as the bullish move in the markets coupled with a budding M&A market have speculators active.  Early morning action was in Bunge (NYSE: BG), with Monsanto [...]

Poniard Recovering Again (PARD)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) recovered off lows big-time yesterday after the company announced an updated positive clinical data from its Phase 2 trial of Picoplatin in colorectal cancer and new Phase 1 cardiac safety trial results.  Shares are continuing the recover this morning with a 10.9% gain to $2.71 on over 425,000 shares as [...]

Netlist Enters Slop Territory (NLST)

Netlist Inc. (NASDAQ: NLST) gave back one-third of its price yesterday.  The stock is starting to remind traders of K-Tel from the 1990′s.  While there is no real news, the stock already hit its inflection point of buyer exhaustion on Monday.  This used to trade under 100,000 shares, let alone anything close to 1 million [...]

DryShips Takes on Water in Offering (DRYS)

DryShips, Inc. (NASDAQ: DRYS) is holding up better than it was last night.  The shipper continued its capital raising path announcing that it is selling $300 million in notes but is also entering a share loan agreement for $150 million with Deutsche Bank (the underwriter).  Shares were down as much as 7% last night.  At [...]

Citi Says Buy Pulte (PHM)

Pulte Homes Inc. (NYSE: PHM) could be subject to the housing starts figure later this morning, but so far shares are trading higher.  Citigroup raised its rating to BUY in a research call this morning. Shares are trading up 4.7% at $10.05 on almost 40,000 shares as of 8:12 AM EST.  Average volume is 7.7 [...]

VIVUS Mounting (VVUS)

VIVUS Inc. (NASDAQ: VVUS) is popping up hard this morning as the company may soon have a new erectile dysfunction drug on the market if the test results lead to an FDA approval.  It announced positive results in a phase 3 pivotal study evaluating the safety and efficacy of avanafil for the treatment of erectile [...]